XML 49 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Stock-Based Compensation Expense Related to Grants of Employee Stock Options, Restricted Stock Units (RSUs) and Performance and Market Based Awards

We recorded stock-based compensation expense related to grants of employee stock options, restricted stock units (“RSUs”) and performance and market-based awards in our consolidated statements of operations as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of revenue

 

$

566

 

 

$

407

 

 

$

1,548

 

 

$

1,088

 

Research and development

 

 

25,380

 

 

 

12,029

 

 

 

48,595

 

 

 

35,982

 

Sales and marketing

 

 

3,957

 

 

 

3,046

 

 

 

10,960

 

 

 

8,453

 

General and administrative

 

 

8,821

 

 

 

5,857

 

 

 

23,759

 

 

 

15,944

 

Total stock-based compensation expense

 

$

38,724

 

 

$

21,339

 

 

$

84,862

 

 

$

61,467

 

 

Schedule of Share Based Compensation Stock Option Activity

The following table shows stock option activity for the nine months ended September 30, 2020 (in thousands, except weighted-average exercise price and weighted-average contractual term):

 

 

 

Outstanding Options

 

 

 

 

 

 

 

 

 

 

 

Aggregate

 

 

Weighted-

 

 

 

 

 

 

 

Weighted-Average

 

 

Intrinsic Value of

 

 

Average

 

 

 

 

 

 

 

Exercise Price

 

 

Stock Options

 

 

Contractual Term

 

 

 

Stock Options

 

 

(per option)

 

 

Outstanding

 

 

(in years)

 

Balance as of December 31, 2019

 

 

31,204

 

 

$

3.24

 

 

$

89,786

 

 

 

7.19

 

Granted

 

 

1,633

 

 

 

6.55

 

 

 

 

 

 

 

 

 

Forfeited, expired and cancelled

 

 

(19

)

 

 

3.37

 

 

 

 

 

 

 

 

 

Exercised

 

 

(2,435

)

 

 

2.93

 

 

 

 

 

 

 

 

 

Balance as of September 30, 2020

 

 

30,383

 

 

$

3.45

 

 

$

172,404

 

 

 

6.68

 

Weighted-Average Grant Date Fair Value of Stock Options and Related Assumptions

The following table presents the weighted-average grant date fair value and the related assumptions used to estimate the fair value of our stock options:

 

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

Expected term, in years

 

 

6

 

Risk-free interest rates

 

 

0.8

%

Expected volatility

 

 

36.0

%

Dividend yield

 

 

 

Weighted-average estimated fair value of options granted

 

$

2.35

 

Schedule of Share Based Compensation Restricted Stock Units Award Activity

The following table shows a summary of RSU activity for the nine months ended September 30, 2020, which includes performance and market-based awards (in thousands, except weighted-average grant date fair value):

 

 

 

Outstanding RSUs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

Aggregate

 

 

 

 

 

 

 

Grant Date Fair Value

 

 

Intrinsic Value of

 

 

 

Shares

 

 

(per share)

 

 

Unvested RSUs

 

Unvested as of December 31, 2019

 

 

40,188

 

 

$

4.23

 

 

$

245,951

 

Granted

 

 

43,085

 

 

 

8.60

 

 

 

 

 

Vested

 

 

(13,650

)

 

 

4.04

 

 

 

 

 

Forfeited

 

 

(1,946

)

 

 

4.53

 

 

 

 

 

Unvested as of September 30, 2020

 

 

67,677

 

 

$

7.04

 

 

$

619,921